Enviri Reports Mixed Q1 Results, Adjusted EPS Turns Positive, Reaffirms Post-Spin-Off Guidance
Summary
Enviri reported mixed Q1 2026 results with a wider GAAP loss but a positive adjusted diluted EPS, while reaffirming guidance for its post-spin-off businesses as its strategic transformation progresses.
Key Events
-
Q1 Adjusted EPS Turns Positive
Adjusted diluted earnings per share from continuing operations improved significantly to $0.10 in Q1 2026, compared to a loss of $(0.11) in Q1 2025. GAAP diluted loss per share from continuing operations widened to $(0.12) from $(0.10) year-over-year.
-
Adjusted EBITDA Declines Slightly
Adjusted EBITDA for Q1 2026 totaled $65 million, a decrease from $71 million in the prior-year quarter, primarily due to lower performance in Clean Earth and Harsco Rail.
-
Cash Flow Improves
Net cash provided by operating activities increased to $22 million in Q1 2026 from $7 million in Q1 2025. Adjusted free cash flow also improved, reducing its deficit to $(6) million from $(13) million.
-
Guidance Reaffirmed for 'New Enviri'
The company reaffirmed its 2026 Adjusted EBITDA guidance for Harsco Environmental and Harsco Rail, as well as the Proforma Adjusted EBITDA for the 'New Enviri' entity at approximately $140 million (mid-point).
Analysis
Enviri's first-quarter results show a mixed financial picture, but the significant improvement in adjusted diluted EPS, moving from a loss to a profit, is a key positive. While GAAP loss widened and Adjusted EBITDA slightly declined, the company's reaffirmation of its 2026 Adjusted EBITDA guidance for the post-spin-off 'New Enviri' businesses (Harsco Environmental and Harsco Rail) provides crucial stability during its major strategic transformation. The progress towards completing the Clean Earth sale and the spin-off by June 1st is a major focus for investors, and these results indicate the company is executing on its strategic plan.
At the time of this filing, NVRI was trading at $19.48 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $6.87 to $19.99. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.